AdBio partners
Investor profile
Venture capital
AdBio partners has backed 5 European tech companies across 6 funding rounds between 2022 and 2025, joining rounds totalling €145M. Most active in Healthtech. Data as of Nov 2026.
Deals
6
distinct rounds
Companies
5
backed
Active span
2022–2025
4 yrs
Total round €
€145M
sum of rounds joined
Deals by year
distinct rounds / yearAdBio partners — deals by year — interactive chart.
Data table
| AdBio partners — deals by year | |
|---|---|
| 2022 | 1 |
| 2023 | 3 |
| 2025 | 2 |
Top sectors
by dealsAdBio partners — top sectors — interactive chart.
Data table
| AdBio partners — top sectors | |
|---|---|
| Healthtech | 6 |
Stages
by dealsAdBio partners — stages — interactive chart.
Data table
| AdBio partners — stages | |
|---|---|
| Seed | 2 |
| Series B | 2 |
| Other | 1 |
| Series A | 1 |
Countries
by dealsAdBio partners — countries — interactive chart.
Data table
| AdBio partners — countries | |
|---|---|
| France | 3 |
| Spain | 3 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Bpifrance3
- Columbus Venture Partners3
- Invivo Capital Partners3
- European Innovation Council (EIC)2
- Hadean Ventures2
- Sound Bioventures2
- Advent Life Sciences1
- Bioqube Ventures1
- Boehringer Ingelheim Venture Fund1
- CDTI Innovación (Innvierte)1
- CDTI Innvierte1
- Centre for the Development of Industrial Technology (CDTI)1
- EIC Fund1
- Eli lilly and company1
- JDRF T1D Fund1
- JJDC – Johnson & Johnson's fund1
- M Ventures1
- Omnes Capital1
- Roche Venture Fund1
- Swiss VC Pureos Bioventures1
- Takeda Ventures1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Arthex Biotech | Spain | 2 | €74M |
| DiogenX | France | 1 | €28M |
| Astraveus | France | 1 | €17M |
| Tridek-One | France | 1 | €16M |
| Integra Therapeutics | Spain | 1 | €11M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Arthex Biotech | Series B | €42M | 2023-05 |
| Arthex Biotech | Series B | €32M | 2025-09 |
| DiogenX | Series A | €28M | 2023-05 |
| Astraveus | Seed | €17M | 2023-06 |
| Tridek-One | Other | €16M | 2022-09 |
| Integra Therapeutics | Seed | €11M | 2025-09 |